Evaluation of recombinant human interferon alpha-2b structure and stability by in-gel tryptic digestion, H/D exchange and mass spectrometry.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Pharmaceutical and Biomedical Analysis

• Publication date

  2006-02-24

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.JPBA.2005.10.024PMID 16316735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure-Immunogenicity Relationships of Therapeutic Proteins

  2004cited by this paper
• Large-scale protein identification using mass spectrometry.

  2003cited by this paper
• Stabilization of recombinant interferon-α by pegylation for encapsulation in PLGA microspheres

  2003cited by this paper
• Characterisation of interferon α‐2b by liquid chromatography and mass spectrometry techniques

  2003cited by this paper
• Stabilization of recombinant interferon-alpha by pegylation for encapsulation in PLGA microspheres.

  2003cited by this paper
• Use of matrix clusters and trypsin autolysis fragments as mass calibrants in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

  2002cited by this paper
• Purification and conformational properties of a human interferon α2b produced in Escherichia coli

  2001cited by this paper
• Broadband detection electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry to reveal enzymatically and chemically induced deamidation reactions within peptides.

  2001cited by this paper
• Differentiating alpha- and beta-aspartic acids by electrospray ionization and low-energy tandem mass spectrometry.

  2000cited by this paper
• Study on the quality of recombinant proteins using matrix-assisted laser desorption ionization time of flight mass spectrometry.

  1999cited by this paper
• Matrix-assisted laser desorption ionization hydrogen/deuterium exchange studies to probe peptide conformational changes

  1999cited by this paper
• Biopharmaceuticals: Biochemistry and Biotechnology

  1998cited by this paper
• Monitoring recombinant protein drugs: a study of insulin by H/D exchange and electrospray ionization mass spectrometry.

  1997cited by this paper
• Methionine residues as endogenous antioxidants in proteins.

  1996cited by this paper
• Isolation and Characterization of a Monomethioninesulfoxide Variant of Interferon α-2b

  1996cited by this paper
• Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.

  1996cited by this paper
• Isolation and characterization of a monomethioninesulfoxide variant of interferon alpha-2b.

  1996cited by this paper
• Comparative mapping of recombinant proteins and glycoproteins by plasma desorption and matrix-assisted laser desorption/ionization mass spectrometry.

  1994cited by this paper
• Peptide mapping of recombinant human interferon-gamma by reversed-phase liquid chromatography with on-line identification by thermospray mass spectrometry and UV absorption spectrometry.

  1993cited by this paper
• Comparative studies of natural and recombinant proteins by californium-252 plasma desorption and cesium ion liquid secondary ion mass spectrometry

  1990cited by this paper
• Mass spectrometric analysis of recombinant human α-2 interferon

  1989cited by this paper
• Structural characterization of recombinant consensus interferon-alpha.

  1988cited by this paper
• At least three human type alpha interferons: structure of alpha 2.

  1980cited by this paper
• Virus interference. I. The interferon

  1957cited by this paper

• Análise de interferon humano recombinante presente em formulações farmacêuticas

  2017cites this paper
• Formulation and stability of cytokine therapeutics.

  2015cites this paper
• Molecularly imprinted cryogel cartridges for the specific filtration and rapid separation of interferon alpha

  2015cites this paper
• ANÁLISE DA PROPOSTA DE UM BIOPROCESSO PARA OBTENÇÃO DE UM INTERMEDIÁRIO FARMACÊUTICO TENDO COMO BASE A RESOLUÇÃO DA DIRETORIA COLEGIADA 17.

  2014cites this paper
• Assessment of the Degradation Pattern and Extent of PEG Interferon α-2b Using a Stability-Indicating SE-HPLC Assay

  2014cites this paper
• Improved detection of variants in recombinant human interferon alpha-2a products by reverse-phase high-performance liquid chromatography on a core-shell stationary phase.

  2014cites this paper
• Oxidation of Therapeutic Proteins and Peptides: Structural and Biological Consequences

  2013cites this paper
• Electronic Circular Dichroism in Drug Discovery

  2012cites this paper
• Utility of standard pharmacopeial and nonpharmacopeial methods in distinguishing folded, unfolded, and process variant forms of interferon α-2.

  2012cites this paper
• Structural characterization of recombinant therapeutic proteins by circular dichroism.

  2011cites this paper
• Evidence of second harmonic signals in poly(μ 2 -L- alanine-μ 3 -nitrato-sodium (I))

  2010cites this paper
• Análise de innterferon humano recombinante presente em formulações farmacêuticas por espectrometria de massa

  2010cites this paper
• Influence of carbohydrates on the stability and structure of a hyperglycosylated human interferon alpha mutein.

  2010cites this paper
• Evidence of second harmonic signals in poly[m2-L-alanine-m3-nitrato-sodium (I)] crystals

  2010cites this paper
• Physicochemical and biological assays for quality control of biopharmaceuticals: interferon alpha-2 case study.

  2008cites this paper
• Current literature in mass spectrometry.

  2006cites this paper
• 'On-the-fly' hydrogen/deuterium exchange liquid chromatography/mass spectrometry using a dual-sprayer atmospheric pressure ionisation source.

  2006cites this paper
• International Journal of Pharmacy and Biological Sciences (eissn: 2230-7605) Development and Validation of Rp-uplc Method for Quantification of Interferon in Pharmaceutical Preparation of Interferon

  year unknowncites this paper